Nauset Wealth Management’s Pfizer PFE Stock Holding History

Nauset Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$83K	Buy	+1,600	New	+$83K	0.07%	91

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nauset Wealth Management's PFE Position: Q1 2022 in Review

Nauset Wealth Management opened a new position in Pfizer (PFE) in Q1 2022: 1,600 shares worth $83K. The stake represents 0.07% of the portfolio and ranks #91 among its holdings.

3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Nauset Wealth Management held 1,600 shares of Pfizer worth $83K as of Q1 2022.
Pfizer was a new Nauset Wealth Management position in Q1 2022.
Pfizer made up 0.07% of Nauset Wealth Management's portfolio in Q1 2022, its #91 holding.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Nauset Wealth Management's 13F filing for Q1 2022, filed 28 Apr 2022.